Advertisement

Organisation › Details
EMBL (European Molecular Biology Laboratory)
EMBL is Europe’s flagship laboratory for the life sciences, with more than 80 independent groups covering the spectrum of molecular biology. EMBL is international, innovative and interdisciplinary – its 1600 employees, from many nations, operate across five sites: the main laboratory in Heidelberg, and outstations in Grenoble; Hamburg; Hinxton, near Cambridge (the European Bioinformatics Institute), and Monterotondo, near Rome. Founded in 1974, EMBL is an inter-governmental organisation funded by public research monies from its member states. The cornerstones of EMBL’s mission are: to perform basic research in molecular biology; to train scientists, students and visitors at all levels; to offer vital services to scientists in the member states; to develop new instruments and methods in the life sciences and actively engage in technology transfer activities, and to integrate European life science research. Around 230 students are enrolled in EMBL’s International PhD programme. Additionally, the Laboratory offers a platform for dialogue with the general public through various science communication activities such as lecture series, visitor programmes and the dissemination of scientific achievements. *
![]() |
Start | 1974-01-01 established |
![]() |
Industry | BIOTECH |
Industry 2 | bioinformatics (biological software and databases) | |
![]() |
Person | Hentze, Matthias W. (EMBL 201702 Director) |
![]() |
Region | Heidelberg |
Country | Germany | |
Street | 1 Meyerhoftstr. | |
City | 69117 Heidelberg | |
Tel | 06221-387-0 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | F: 1,001 to 5,000 (2015-11-24) |
* Document for »About Section«: | ||
Record changed: 2025-04-24 |
Advertisement

More documents for EMBL (European Molecular Biology Laboratory)
- [1] EMBL. (12/14/23). "Press Release: Using Artificial Intelligence to Discover Therapeutic Antibodies"....
- [2] EMBL. (9/6/22). "Press Release: ERC Proof-of-Concept Grant Provides Way to Realise Commercial Potential of ‘SpaceM’ Technology"....
- [3] EMBL. (7/22/21). "Press Release: DeepMind and EMBL Release the Most Complete Database of Predicted 3D Structures of Human Proteins". London....
- [4] DKFZ (Deutsches Krebsforschungszentrum). (7/6/21). "Press Release: High-throughput Metabolic Profiling of Single Cells"....
- [5] Bruker Corporation. (12/9/19). "Press Release: Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging". Washington, DC....
- [6] Velabs Therapeutics GmbH. (6/27/19). "Press Release: Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme". Heidelberg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top